Back
Lineage Cell Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
LCTX
Lineage Cell Therapeutics
Last Price:
$1.00
Seasonality Move:
4.41%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LCTX is experiencing selling pressure, which indicates risk of future bearish movement.
Lineage Cell Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.02 | Buy |
| 20-day SMA: | 0.99 | Buy |
| 50-day SMA: | 0.75 | Buy |
| 200-day SMA: | 0.67 | Buy |
| 8-day EMA: | 0.85 | Buy |
| 20-day EMA: | 0.52 | Buy |
| 50-day EMA: | 0.25 | Buy |
| 200-day EMA: | 0.07 | Buy |
Lineage Cell Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 59.74 | Buy |
| Chaikin Money Flow: | -836496 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.83 - 1.05) | Buy |
| Bollinger Bands (100): | (0.41 - 0.83) | Buy |
Lineage Cell Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Lineage Cell Therapeutics Stock
Is Lineage Cell Therapeutics Stock a Buy?
-
Lineage Cell Therapeutics share price is 1.02 while LCTX 8-day simple moving average is 1.02, which is a Buy signal.
-
The stock price of LCTX is 1.02 while Lineage Cell Therapeutics 20-day SMA is 0.99, which makes it a Buy.
-
Lineage Cell Therapeutics 50-day simple moving average is 0.75 while LCTX share price is 1.02, making it a Buy technically.
-
LCTX stock price is 1.02 and Lineage Cell Therapeutics 200-day simple moving average is 0.67, creating a Buy signal.
LCTX Technical Analysis vs Fundamental Analysis
Sell
47
Lineage Cell Therapeutics (LCTX)
is a Sell
Is Lineage Cell Therapeutics a Buy or a Sell?
-
Lineage Cell Therapeutics stock is rated a SellThe current Lineage Cell Therapeutics [LCTX] share price is $1.02. The Score for LCTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Lineage Cell Therapeutics Stock Info
Market Cap:
232.9M
Price in USD:
1.02
Share Volume:
1.4M
Lineage Cell Therapeutics 52-Week Range
52-Week High:
1.15
52-Week Low:
0.37
Sell
47
Lineage Cell Therapeutics (LCTX)
is a Sell
Lineage Cell Therapeutics Share Price Forecast
-
What is the Lineage Cell Therapeutics stock price today?The Lineage Cell Therapeutics stock price is 1.02 USD today.
-
Will LCTX stock go up or go down?Lineage Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Lineage Cell Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lineage Cell Therapeutics is overvalued.
Is Lineage Cell Therapeutics Stock a Buy?
-
Lineage Cell Therapeutics share price is 1.02 while LCTX 8-day exponential moving average is 0.85, which is a Buy signal.
-
The stock price of LCTX is 1.02 while Lineage Cell Therapeutics 20-day EMA is 0.52, which makes it a Buy.
-
Lineage Cell Therapeutics 50-day exponential moving average is 0.25 while LCTX share price is 1.02, making it a Buy technically.
-
LCTX stock price is 1.02 and Lineage Cell Therapeutics 200-day simple moving average is 0.07, creating a Buy signal.
Fundamental Analysis of Lineage Cell Therapeutics
Is Lineage Cell Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.01 per share, an increase this year of $0.01 per share, and an increase next year of $0.05 per share.
Technical Analysis of Lineage Cell Therapeutics
Should I short Lineage Cell Therapeutics stock?
-
LCTX Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting Lineage Cell Therapeutics is a Buy
-
Lineage Cell Therapeutics Relative Strength Index (RSI) is 59.74, which suggest Lineage Cell Therapeutics is overbought
-
The Bollinger Bands (25) for Lineage Cell Therapeutics is (0.83 - 1.05), which suggest Lineage Cell Therapeutics is a Buy
-
The Bollinger Bands (100) for Lineage Cell Therapeutics is (0.41 - 0.83), which suggest Lineage Cell Therapeutics is a Buy
* Lineage Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.